Trials / Recruiting
RecruitingNCT06405945
Cervical Cancer Susceptible Population Classification
Evalutaion of the SNPs Test in Average Cervical Cancer Screening Episode
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Anhui Provincial Hospital · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | PCR and sequence | sequence the mutatation SNPs |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2034-04-30
- Completion
- 2036-06-01
- First posted
- 2024-05-09
- Last updated
- 2024-05-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06405945. Inclusion in this directory is not an endorsement.